Issuance of Series 10 stock acquisition rights to directors, executive officers and employees
First written in FY2024-Q2. 2 of 3 entries say "Restated". Latest entry: FY2025.
- FY2025RestatedAnnual report
「Number of stock acquisition rights (units) 70 Class, terms and number of shares underlying the stock acquisition rights Common shares 7,000 Exercise price (yen) 2,433 Exercise period 15 January 2026 to 14 January 2034」
At the fiscal year-end, 70 Series 10 rights covering 7,000 shares remained outstanding; the exercise price and period continued to be disclosed. - FY2024RestatedAnnual report
「Number of stock acquisition rights (units) 74 Class, terms and number of shares underlying the stock acquisition rights Common shares 7,400 Exercise price (yen) 2,433 Exercise period 15 January 2026 to 14 January 2034」
At the fiscal year-end, 74 Series 10 rights covering 7,400 shares remained outstanding; the exercise price and period were unchanged. - FY2024-Q2First statedAnnual report
「Company directors 1 Company executive officers 2 Company employees 24 Number of stock acquisition rights (units) 148 Class, terms and number of shares underlying the stock acquisition rights Common shares 14,800 Exercise price (yen) ¥2,433 per share Exercise period 15 January 2026 to 14 January 2034」
Series 10 stock acquisition rights were issued to directors, executive officers and employees, covering 14,800 shares at an exercise price of ¥2,433 per share, exercisable from 15 January 2026 through 14 January 2034.